Percutaneous mitral and tricuspid edge-to-edge repair as a bridge therapy to heart transplantation in advanced heart failure secondary to human immunodeficiency virus: a case report.
Heberto Aquino-BrunoElias Noel Andrade-CuellarJulieta D Morales-PortanoMarco Antonio Alcántara-MeléndezPublished in: European heart journal. Case reports (2023)
In patients with advanced HF due to HIV, HT is an adequate treatment option. When there are functional mitral and tricuspid regurgitation and severe PH, despite optimal treatment according to current guidelines, percutaneous mitral and tricuspid repair therapy appears to be safe and effective for control of severe PH as a bridge measure for cardiac transplantation.
Keyphrases
- mitral valve
- human immunodeficiency virus
- aortic stenosis
- left ventricular
- aortic valve
- heart failure
- antiretroviral therapy
- hepatitis c virus
- transcatheter aortic valve replacement
- left atrial
- hiv infected
- ejection fraction
- early onset
- minimally invasive
- hiv aids
- hiv positive
- cardiac resynchronization therapy
- mesenchymal stem cells
- men who have sex with men
- hiv testing
- drug induced